Women may soon have a quicker path to getting diagnosed with endometriosis as new tests become available through GPs. The National Institute for Health and Care Excellence (NICE) has approved two non-invasive tests that could significantly reduce the lengthy wait time for a diagnosis, which currently averages over nine years.
Endometriosis, a painful condition affecting approximately one in 10 women of reproductive age in the UK, involves the growth of womb-like cells in other body parts, leading to symptoms like pelvic pain, heavy periods, fatigue, and infertility. The newly approved tests, EndoSure and Endotest, will be introduced in NHS practices for three years to gather more evidence on their effectiveness. These tests, although not standalone diagnostic tools, aim to identify individuals who require further examination, potentially expediting treatment for women suffering from the condition.
Endotest analyzes saliva samples for microRNAs associated with endometriosis, while EndoSure measures gut electrical signals using abdominal sensor pads. A survey conducted by the All-Party Parliamentary Group on Endometriosis revealed that many women had to visit their GPs numerous times before receiving a diagnosis, with some even resorting to A&E visits due to symptoms.
Dr. Anastasia Chalkidou, NICE’s healthtech program director, emphasized the importance of early identification, stating that the current delay in diagnosing endometriosis significantly impacts women’s quality of life. The new tests offer primary care professionals non-invasive tools to detect endometriosis earlier, potentially leading to improved and timelier treatment for affected individuals.
One beneficiary of the new tests, 15-year-old Simran Chavda from Huddersfield, shared her relief upon receiving a diagnosis after years of uncertainty and pain. Her mother, Sharan Uppal, opted for the gut test, which yielded positive results, paving the way for appropriate treatment. Dr. Gail Busby, a consultant gynaecologist at Manchester University NHS Foundation Trust, highlighted the transformative impact of early diagnosis in improving the lives of individuals affected by endometriosis and reducing the burden on healthcare resources.
The introduction of these new tests marks a significant step towards addressing the long-standing challenge of delayed endometriosis diagnoses, offering hope for faster and more effective treatment for women suffering from this debilitating condition.